George Katibah
CancerVax Inc., a Lehi-based developer of a breakthrough universal cancer treatment platform that will use the body’s immune system to fight cancer, has announced Dr. George Katibah as chief scientific officer. Katibah is an expert in oncology, immunology, host-pathogen interactions and personalized medicine. He previously served as director of discovery biology at RAPT Therapeutics. Prior to that, he was head of biochemistry and senior scientist at Aduro Biotech.